Medicine & AI to Improve Outcomes by Discovering Undiagnosed Patients- NHS Clinicians Presenting at HIMSS

Predicting Length-of-Stay & Risk of Mortality for ICU Patients

Pangaea Data Awarded Top Tier Co-Sell Partnership Status by Microsoft

Pangaea Named ‘Digital Solution of the Year’ by UK Government’s Department for International Trade

WHITEPAPER: How can Pharmaceutical & Healthcare Providers Collaborate in a Financially Sustainable & Scalable Manner to Improve Patient Outcomes?

Go back

Applying AI & Clinical Guidelines to Find 6x More Untreated Patients

12:15PM - 1:00PM CET, Agora IT Stage, May 22nd 2024, Paris, France

Panel discussion: Deploying Disruptive Innovation in Healthcare – Microsoft, NVIDIA, Pangaea Data

Location: Agora IT stage

Venue: Paris Expo – Porte de Versailles – Hall 7.2

Pangaea’s founder, Dr. Vibhor Gupta, will be hosted on a panel with Microsoft and NVIDIA discussing the application of Pangaea’s product platform to find the up to 90% of currently untreated (undiagnosed, misdiagnosed, miscoded, uncontrolled, at-risk) patients for 7,000 hard-to-diagnose conditions, without transacting data or disrupting existing clinical workflows. For example, sponsored by a global pharmaceutical company, Pangaea’s product was applied to find 6x more undiagnosed and miscoded COPD and at-risk CKD patients, compared to if ICD codes were used. This work is now being scaled across healthcare providers in Europe and the USA.

Pangaea will also be showcased at the Microsoft booth (F67) on Wednesday 22nd May

Please let us know if you are available to meet by registering through the form below or emailing us at

Register to Meet Us


Dr. Vibhor Gupta
Director & Founder
Pangaea Data